(Q35214863)

7 August 2017

1 reference

title

Preventing saphenous vein graft failure: does gene therapy have a role? (English)

1 reference

7 August 2017

0 references

Enoch F Akowuah

1

1 reference

7 August 2017

Paul J Sheridan

series ordinal

2

1 reference

7 August 2017

Graham J Cooper

series ordinal

3

1 reference

7 August 2017

Christopher Newman

series ordinal

4

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

The Annals of Thoracic Surgery

7 August 2017

published in

1 reference

7 August 2017

volume

76

1 reference

7 August 2017

issue

3

1 reference

7 August 2017

page(s)

959-966

1 reference

The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Fate of venous grafts: the past, the present and the future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Frequency of repeat coronary bypass or coronary angioplasty after coronary artery bypass surgery using saphenous venous grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Nature and pressure dependence of damage induced by distension of human saphenous vein coronary artery bypass grafts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Endothelial cell injury in cardiovascular surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Development of nonthrombogenicity of injured rabbit aortas despite inhibition of platelet adherence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

The future of saphenous vein as a coronary artery bypass conduit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Different proliferative properties of smooth muscle cells of human arterial and venous bypass vessels: role of PDGF receptors, mitogen-activated protein kinase, and cyclin-dependent kinase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Comparison of uptake and degradation of low density lipoproteins by arteries and veins of rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Coronary Bypass Surgery with Internal-Thoracic-Artery Grafts — Effects on Survival over a 15-Year Period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Unilateral versus bilateral internal mammary revascularization. Survival and event-free performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Does it make sense to use two internal thoracic arteries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Superiority of bilateral internal thoracic artery grafting: it's been a long time comin'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Benefit of bilateral over single internal mammary artery grafts for multiple coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Two internal thoracic artery grafts are better than one.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

The radial artery versus the saphenous vein graft in contemporary CABG: a case-matched study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

The radial artery in coronary surgery: a 5-year experience--clinical and angiographic results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Composite arterial Y graft has less coronary flow reserve than independent grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Aspirin and mortality from coronary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Recombinant gene expression in vivo within endothelial cells of the arterial wall

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Seeding of intravascular stents with genetically engineered endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Gene therapy for restenosis: getting nearer the heart of the matter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Efficient and selective adenovirus-mediated gene transfer into vascular neointima

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

The advent of adenovirus. Gene therapy for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

In vivo gene transfer into injured carotid arteries. Optimization and evaluation of acute toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Vasomotor dysfunction early after exposure of normal rabbit arteries to an adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Local delivery of plasmid DNA into rat carotid artery using ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Cell cycle inhibition preserves endothelial function in genetically engineered rabbit vein grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Comparison of response to injury in organ culture of human saphenous vein and internal mammary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Adventitial remodeling after coronary arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Genetic engineering of vein grafts resistant to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Saphenous vein graft protection: effects of c-myc antisense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Sustained reduction of neointima with c-myc antisense oligonucleotides in saphenous vein grafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Tissue inhibitors of metalloproteinases and metalloproteinases in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2900505-8

10.1016/S0003-4975(03)00505-8

7 January 2021

Identifiers

DOI

1 reference

7 August 2017

1 reference